Intermountain Healthcare Awarded the 2017 $100,000 Hearst Health Prize in Partnership With the Jefferson College of Population Health

NEW YORK, NY and PHILADELPHIA, PA–(Marketwired – March 28, 2017) – Hearst Health, a division of Hearst, and the Jefferson College of Population Health of Thomas Jefferson University, today announced that Utah-based Intermountain Healthcare is the winner of the 2017 Hearst Health Prize. Intermountain was awarded the prize for its Mental Health Integration program, which embeds mental health screening and treatment within primary care and select specialty practices. The Hearst Health Prize is an annual $100,000 award given in recognition of an organization’s or individual’s outstanding achievement in managing or improving health in the U.S.

The announcement was made by Gregory Dorn, MD, MPH, president of Hearst Health, and David B. Nash, MD, MBA, dean of the Jefferson College of Population Health, who is also one of the judges, at the 17th annual Population Health Colloquium in Philadelphia.

“The caregivers at Intermountain are grateful to receive this recognition and award,” said Marc Harrison, MD, Intermountain president and CEO. “It honors our commitment to our patients, their families, and the communities we serve. It honors our caregivers with whom our patients trust to provide the highest quality, effective, and affordable care.”

Approximately 43 million American adults (18 percent of the total adult population in the U.S.) have a mental illness. In 2000, Intermountain Healthcare created a Mental Health Integration program for patients that made mental health evaluation and service part of the routine care for all patients seeking care at Intermountain, with an emphasis on primary care. It utilizes a team-based approach, built upon systematic, evidence-based medicine that is collaborative and measurable, to help patients and their families manage the complexity of both mental and physical health.

More than 100,000 patients were tracked over a 10-year period to observe their outcomes and interactions. Below are statistics highlighting the impact of the program, based on this retrospective longitudinal cohort study between 2003 and 2013 comparing Team-Based Care to Traditional Practice Medicine:

  • Patients perceived physicians were more sensitive to their emotional or mental health concerns, explained things better, and provided better overall quality of care and services under the Mental Health Integration approach (p<.05)
  • The Team-Based Care model had higher rates of active depression screening (46 vs. 24.1 percent); adherence to diabetes care bundle (24.6 vs. 19.5 percent); and documentation of self-care plans (48.4 vs. 8.7 percent)
  • Rates of healthcare utilization were lower for Team-Based Care patients (18.1 vs. 23.5 visits per 100 person-years)
  • Significant reductions in payments to the delivery system were associated with the Team-Based Care group vs. the Traditional Practice Medicine ($3,400.62 vs. $3,515.71) and were lower than the investments in the Team-Based Care program

Learn more about Intermountain’s Mental Health Integration program: https://youtu.be/W1p_AejTF1U

“Intermountain Healthcare’s Mental Health Integration program is very impressive in its focus on clinical quality, improving outcomes, enhancing the patient experience and providing value,” Dorn said. “There is much to learn from Intermountain’s success and one of the fundamental goals of the Hearst Health Prize is to proliferate these best practices so that other programs and patients can benefit from this work.”

“Treatment and management of mental health conditions is a critical issue in the population health field and we congratulate the Intermountain Healthcare team for creating and implementing such an effective program,” Nash said. “The Hearst Health Prize submissions this year covered a broad range of issues and the judges came away with new insights about the good work that is being done across the country in a variety of settings.”

The Hearst Health Prize applications were evaluated by a distinguished panel of judges based on the program’s population health impact or outcome, demonstrated by measurable improvement; use of evidence-based interventions and best practices to improve the quality of care; promotion of communication, collaboration and engagement; scalability and sustainability; and innovation. Intermountain Healthcare was the highest scoring in these criteria based on the judges’ evaluation.

The two Hearst Health Prize finalists are (in alphabetical order):

  • American Heart Association/American Stroke Association: “Target: Stroke” is a national initiative aimed at increasing the number of eligible stroke patients receiving tissue plasminogen activator (tPA) within the specified time frame in order to break up blood clots to protect the brain from damage that may cause disability or death. Hospitals participating in the program dropped average treatment times from 74 minutes to 59 minutes. For more information visit: http://www.heart.org/HEARTORG/.

The following organizations received Honorable Mention for their programs (in alphabetical order):

  • Baylor College of Medicine
  • Children’s Health System of Texas
  • Corporation for Supportive Housing (CSH)
  • Dornsife School of Public Health, Drexel University
  • Metropolitan Chicago Breast Cancer Task Force
  • NewYork-Presbyterian Hospital
  • Rush University Medical Center

For additional information about the Hearst Health Prize, please go to www.jefferson.edu/HearstHealthPrize.

About Hearst Health:

The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MedHOK, Hearst Health International, Hearst Health Ventures and the Hearst Health Innovation Lab (www.hearsthealth.com). The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 84 percent of discharged patients, 177 million insured individuals, 60 million home health visits, and 3.1 billion dispensed prescriptions.

About the Jefferson College of Population Health:

The Jefferson College of Population Health (JCPH) is the first college of its kind in the country. Established in 2008, it is part of Thomas Jefferson University, a leading academic health center founded in Philadelphia in 1824 as Jefferson Medical College (now Sidney Kimmel Medical College). The College is dedicated to exploring the policies and forces that define the health and well-being of populations. Its mission is to prepare leaders with global vision to examine the social determinants of health and to evaluate, develop and implement health policies and systems that will improve the health of populations and thereby enhance the quality of life. Jefferson College of Population Health provides exemplary graduate academic programming in population health, public health, health policy, healthcare quality and safety, and applied health economics and outcomes research. Its educational offerings are enhanced by research, publications and continuing education and professional development offerings in these areas.

About Intermountain Healthcare:

Intermountain Healthcare is a not-for-profit system of 22 hospitals, 185 clinics, a Medical Group with about 1,500 employed physicians and advanced practitioners, a health plans group called SelectHealth, and other medical services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit www.intermountainhealthcare.org.

Image Available: http://www.marketwire.com/library/MwGo/2017/3/27/11G134230/Images/Hearst_Health_Prize_2017_winner_photo-754c027280a9947c9a4a00424cd4293d.jpg

Embedded Video Available: https://www.youtube.com/watch?v=W1p_AejTF1U&t=6s

Ads

You May Also Like

Amarin Provides Preliminary 2018 Results and 2019 Outlook

U.S. Sales Force Increased to 400 Sales Professionals for 2019 Following Unprecedented Positive Results ...

IASLC邀請肺癌專業人士參加環球分子診斷調查

胸部惡性腫瘤屆的環球領袖開展調查,以評估如何改善環球分子診斷丹佛, July 13, 2018 (GLOBE NEWSWIRE) -- 國際肺癌研究協會(IASLC)鼓勵所有參與肺癌患者分子診斷的人員參加一項環球調查,本調查旨在評估最佳實務的實施情况及最終制定分子診斷的環球指引。欲參加IASLC肺癌分子診斷環球調查,請瀏覽www.iaslc.org/survey。 IASLC的醫學博士、哲學博士和執行長Fred R. Hirsch表示,「肺癌科學的發展速度非常快。」Hirsch博士亦指出,「為了確保患者護理跟上科學的發展,我們需要瞭解實施及採用新療法的障礙。在收集數據、利用和傳播數據以改變患者治療效果方面,IASLC擁有獨特的優勢。」 許多指引建議在擁有腺癌組織學成分的晚期非小細胞肺癌(NSCLC)中測試致瘤分子驅動因子,例如EGFR、ROS1、ALK和BRAF。針對該等特定致癌分子驅動因子的療法可以使患者延年益壽,但是在開始治療之前需要知道是否存在驅動因子。 為瞭解肺癌分子診斷的現狀以及任何區域性挑戰和實施障礙,包括為什麽並非所有地區均參與分子診斷,專家參與本調查至關重要。IASLC邀請醫療保健專業人員和其他利益相關方參與本調查。本調查提供英語、中文、日語、葡萄牙語和西班牙語版本。 肺癌分子診斷的IASLC環球調查結果將1)釐定分子診斷的現狀,2)揭露任何區域實施挑戰或障礙,及3)為制定未來策略提供相關資訊,以克服向環球肺癌患者普及分子診斷的障礙。主要發現摘要將與受訪者分享,並且完整報告將會提交至IASLC官方期刊Journal ...